Chimeric human/murine monoclonal IgM antibodies to HIV-1 Nef antigen expressed on chronically infected cells.
Human IgM antibody (Ab) to gangliosides induced cytolysis of HIV-1-infected cells by homologous human complement. We expected that any human IgM Ab reactive with HIV-1 infected cells could cause complement-mediated cytolysis. The trans-chromosome mouse (TC mouse) contains human chromosomes harboring genes responsible for immunoglobulin production. Spleen cells from TC mice immunized with recombinant Nef were fused with mouse myeloma cells to generate hybridomas, and we selected those that produced human mu-chain-positive Abs reactive with Nef fixed on an ELISA plate. However, the L-chain of the monoclonal Abs (mAbs) were murine lambda in type and were chimeric, and we could not succeed in obtaining mAb with human mu- and human kappa-chains. The chimeric mAbs reacted with the HIV-1 infected cells as seen with flow cytometric analysis, and the surface expression of Nef was also detectable on chronically infected OM10.1 cells which had no detectable gp120. However, although the reaction of the chimeric IgM mAb with HIV-1-infected MOLT4 cells induced C3 deposition on cell surfaces on incubation with fresh human serum, the cells remained unlysed, as determined by 51Cr release assay. The amount of Nef antigen on the cells might not have been high enough to overcome the function of HRF20 (CD59) that restricts formation of membrane attack complexes of homologous complement. However, combination of anti-Nef IgM mAb with other IgM mAbs reactive with the surface of HIV-1-infected cells may induce a synergistic effect in complement mediated cytolysis.
Department of Biodefense, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467-8601, Japan.
Masahiro
M
Kawai
Lianying
L
He
Takeshi
T
Kawamura
Shinya
S
Omoto
Yoichi R
YR
Fujii
Noriko
N
Okada
D000818:Animals; D000911:Antibodies, Monoclonal / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D002478:Cells, Cultured; D003176:Complement C3 / Q000378:metabolism; D015693:Gene Products, nef / Q000276:immunology*; D015483:HIV Antibodies / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D015488:HIV Antigens / Q000276:immunology*; D006801:Humans; D007114:Immunization; D007075:Immunoglobulin M / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D008957:Models, Genetic; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D020298:U937 Cells
D000911:Antibodies, Monoclonal; D003176:Complement C3; D015693:Gene Products, nef; D015483:HIV Antibodies; D015488:HIV Antigens; D007075:Immunoglobulin M; D011993:Recombinant Fusion Proteins